| Ytd | 16.91% | |
| 1y | 52.39% |
| Open | 243.00 | Prev Close | 237.18 | Low | 236.66 | High | 258.30 | Mkt Cap | 56.27B |
| Vol | 0.00 | Avg Vol | 2.33M | EPS | 10.43 | P/E | 23.04 | Forward P/E | 19.68 |
| Beta | 0.52 | Short Ratio | 2.62 | Inst. Own | 89.57% | Dividend | 2.05 | Div Yield | 0.87 |
| Ex Div Date | 07-01 | Earning | 08-11 | 50-d Avg | 226.07 | 200-d Avg | 211.11 | 1yr Est | 252.40 |
Cardinal Health beats fiscal Q4 EPS estimates as profit surges, while revenues miss; fiscal 2027 gui
Cardinal Health NYSE: CAH reported fourth-quarter fiscal 2026 results marked by growth in revenue, o
Cardinal Health (CAH) shares are rising following a robust earnings report that surpassed expectatio
Cardinal Health, Inc. (CAH) Q4 2026 Earnings Call Transcript
Pre-market futures are correcting Monday's slight selloff at this hour; ultimately, as we had said i
We don't expect much movement either direction until inflation reports begin to hit the tape Wednesd
Although the revenue and EPS for Cardinal (CAH) give a sense of how its business performed in the qu
CAH stock hits new 52-week high as Cardinal Health beats Q4 earnings, boosts FY27 outlook, and appro
U.S. stocks traded mixed this morning, with the Dow Jones index gaining more than 150 points on Tues
US stocks mixed, Dow up 150 points. Industrials gain 1%, communication services fall 1.1%. Cardinal
Cardinal Health (CAH) came out with quarterly earnings of $2.91 per share, beating the Zacks Consens
U.S. drug distributor Cardinal Health on Tuesday forecast fiscal 2027 profit well above Wall Street
Cardinal Health reports mixed quarterly performance across its business segments as earnings get a l
Cardinal Health had a mixed fiscal fourth quarter in terms of sales across its two main business lin
Cardinal Health recently completed an additional $350 million accelerated share repurchase program,
Fourth quarter revenue increased 6% to $63.7 billion Fourth quarter GAAP 1 diluted EPS increased 70%
DUBLIN, Ohio,, Aug. 11, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Bo
Stocks closed mostly lower on Monday, with the Fear and Greed index remaining in Greed zone. Investo
With U.S. stock futures trading mixed this morning on Tuesday, some of the stocks that may grab inve
U.S. stock futures mixed, focus on Super Micro Computer Inc, Upwork Inc, Cardinal Health Inc, Babcoc
Cardinal Health, Inc. (NYSE:CAH) will release its fourth quarter earnings report before the opening
CAH to release Q4 earnings on Aug. 11, analysts expect EPS of $2.42 and revenue of $65.11B. Recently
Earnings set to hit the tape Tues. Options market implying post-print swings for 5 stocks, from heal
Cardinal Health heads into Q4 earnings with pharma, specialty and higher-margin businesses in focus
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and
Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a
Beyond analysts' top-and-bottom-line estimates for Cardinal (CAH), evaluate projections for some of
Cardinal (CAH) possesses the right combination of the two key ingredients for a likely earnings beat
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi
Cardinal Health (CAH) closed the most recent trading day at $235.6, moving +2.42% from the previous
Cardinal (CAH) is well positioned to outperform the market, as it exhibits above-average growth in f
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should tak
In the most recent trading session, Cardinal Health (CAH) closed at $232.51, indicating a +1.38% shi
Citigroup analyst Daniel Grosslight maintains Cardinal Health (NYSE:CAH) with a Buy and raises th
Mizuho analyst Steven Valiquette maintains Cardinal Health (NYSE:CAH) with a Outperform and raise
CAH is set to buy two home-care businesses for about $360 million, expanding diabetes and urology re
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and
Cardinal Health will acquire the Diabetes Health business of AdaptHealth Corp. (NASDAQ:AHCO), and, i
Continues the Company's multi-year effort to focus its portfolio on its core sleep, respiratory,
UBS analyst Kevin Caliendo maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price t
TD Cowen analyst Charles Rhyee maintains Cardinal Health (NYSE:CAH) with a Buy and raises the pri
B of A Securities analyst Allen Lutz maintains Cardinal Health (NYSE:CAH) with a Buy and raises t
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
3 health care stocks flashing warning: CAH RSI 77.7, TGTX RSI 79.8, AMRX RSI 76.9; all overbought, b
JP Morgan analyst Lisa Gill maintains Cardinal Health (NYSE:CAH) with a Neutral and lowers the pr
Citigroup analyst Daniel Grosslight maintains Cardinal Health (NYSE:CAH) with a Buy and lowers th
TD Cowen analyst Charles Rhyee maintains Cardinal Health (NYSE:CAH) with a Buy and raises the pri